Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Budget Opioid Settlement topic
No spam. Unsubscribe anytime.
Board adopts FY26 budget amendment and signs on to opioid‑manufacturer settlements
Summary
On consent the Nelson County Board approved a multi‑line FY26 budget amendment and authorized participation in proposed nationwide settlements with opioid manufacturers, directing the County Attorney to execute settlement documents; appropriations and transfers totaling several hundred thousand dollars and a capital transfer of $305,191.84 were noted in the packet.
The Nelson County Board of Supervisors approved a Consent Agenda on Sept. 9 that included a fiscal-year 2025–26 budget amendment (R2025‑66) and a resolution authorizing Nelson County’s participation in proposed opioid‑manufacturer settlements (R2025‑67).
The budget amendment packet lists numerous line‑item appropriations and transfers across general and capital funds. Notable entries include a capital‑fund transfer totaling $305,191.84 (Resolution R2025‑66) and a general‑fund appropriations schedule with multiple revenue and expenditure adjustments. The board adopted the amendment by roll‑call vote as part of the consent agenda (3–0).
In a separate consent resolution (R2025‑67) the board approved participation in the proposed settlements with manufacturers identified in the packet (Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun and Zydus) and directed the County Attorney to execute documents to effectuate participation and required releases. The resolution frames Nelson County’s participation as part of the Virginia Opioid Abatement Fund and references prior distributor and manufacturer settlements as precedent for administration and allocation.
Board members took no separate roll‑call on the opioid resolution beyond the consent‑agenda vote. The resolution states, as background, that the manufacturers have negotiated a nationwide aggregate payment of approximately $720 million and that county participation will allow Nelson to recover its share for abatement of opioid‑related impacts.
